107 related articles for article (PubMed ID: 10425356)
1. Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride.
Agatonovic-Kustrin S; Wu V; Rades T; Saville D; Tucker IG
Int J Pharm; 1999 Jul; 184(1):107-14. PubMed ID: 10425356
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine hydrochloride X-ray assay using a neural network.
Agatonovic-Kustrin S; Wu V; Rades T; Saville D; Tucker IG
J Pharm Biomed Anal; 2000 Jul; 22(6):985-92. PubMed ID: 10857567
[TBL] [Abstract][Full Text] [Related]
3. Solid state assay of ranitidine HCl as a bulk drug and as active ingredient in tablets using DRIFT spectroscopy with artificial neural networks.
Agatonovic-Kustrin S; Tucker IG; Schmierer D
Pharm Res; 1999 Sep; 16(9):1477-82. PubMed ID: 10496668
[TBL] [Abstract][Full Text] [Related]
4. Solid state characterization and crystal structure from X-ray powder diffraction of two polymorphic forms of ranitidine base.
de Armas HN; Peeters OM; Blaton N; Van Gyseghem E; Martens J; Van Haele G; Van Den Mooter G
J Pharm Sci; 2009 Jan; 98(1):146-58. PubMed ID: 18393299
[TBL] [Abstract][Full Text] [Related]
5. Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD.
Agatonovic-Kustrin S; Rades T; Wu V; Saville D; Tucker IG
J Pharm Biomed Anal; 2001 Jul; 25(5-6):741-50. PubMed ID: 11377056
[TBL] [Abstract][Full Text] [Related]
6. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
7. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Physical Characterization of a Diclofenac-Ranitidine Co-precipitate for Improving the Dissolution of Diclofenac.
Gaitano RO; Calvo NL; Narda GE; Kaufman TS; Maggio RM; Brusau EV
J Pharm Sci; 2016 Mar; 105(3):1258-68. PubMed ID: 26886308
[TBL] [Abstract][Full Text] [Related]
9. Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms.
Mirmehrabi M; Rohani S; Murthy KS; Radatus B
Int J Pharm; 2004 Sep; 282(1-2):73-85. PubMed ID: 15336383
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
[TBL] [Abstract][Full Text] [Related]
11. X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres.
Dash AK; Khin-Khin A; Suryanarayanan R
J Pharm Sci; 2002 Apr; 91(4):983-90. PubMed ID: 11948537
[TBL] [Abstract][Full Text] [Related]
12. An accurate quantitative analysis of polymorphs based on artificial neural networks.
Okumura T; Nakazono M; Otsuka M; Takayama K
Colloids Surf B Biointerfaces; 2006 May; 49(2):153-7. PubMed ID: 16621473
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
Német Z; Kis GC; Pokol G; Demeter A
J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine HCl: tablet film coating acidity and discoloration.
Eyjolfsson R
Drug Dev Ind Pharm; 2000 Jun; 26(6):693-4. PubMed ID: 10826119
[TBL] [Abstract][Full Text] [Related]
15. Inline filtration of ranitidine hydrochloride solutions.
Schlatter J; Saulnier JL
Am J Health Syst Pharm; 1998 Apr; 55(8):840, 843. PubMed ID: 9568242
[No Abstract] [Full Text] [Related]
16. [Analytical application of phosphotungstic acid complexes. Fabrication and characterisation of membrane selective electrodes for some H2 antihistaminics].
Apostu M; Dorneanu V
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):856-9. PubMed ID: 20201281
[TBL] [Abstract][Full Text] [Related]
17. Recognition of active ingredients in tablets by chemometric processing of X-ray diffractometric data.
Komsta Ł; Maurin JK
Talanta; 2010 Jul; 82(2):850-3. PubMed ID: 20602980
[TBL] [Abstract][Full Text] [Related]
18. Subtleties in crystal structure solution from powder diffraction data using simulated annealing: ranitidine hydrochloride.
Huq A; Stephens PW
J Pharm Sci; 2003 Feb; 92(2):244-9. PubMed ID: 12532373
[TBL] [Abstract][Full Text] [Related]
19. Stability of ranitidine hydrochloride in water for injection in glass vials and plastic syringes.
Nahata MC; Morosco RS; Fox J
Am J Health Syst Pharm; 1996 Jul; 53(13):1588-90. PubMed ID: 8809282
[No Abstract] [Full Text] [Related]
20. Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride.
Teraoka R; Otsuka M; Matsuda Y
J Pharm Sci; 1993 Jun; 82(6):601-4. PubMed ID: 8331533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
